121 related articles for article (PubMed ID: 29719371)
1. P&T Committee Drug Prioritization Criteria: A Tool Developed by a Saudi Health Care System.
Esba LCA; Almodaimegh H; Alhammad A; Ferwana M; Yousef C; Ismail S
P T; 2018 May; 43(5):293-300. PubMed ID: 29719371
[TBL] [Abstract][Full Text] [Related]
2. The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.
Weekes LM; Day RO
Drug Saf; 1998 Mar; 18(3):153-9. PubMed ID: 9530535
[TBL] [Abstract][Full Text] [Related]
3. Drug formulary decision-making: Ethnographic study of 3 pharmacy and therapeutics committees.
Schiff GD; Tripathi JB; Galanter W; Paek JL; Pontikes P; Fanikos J; Matta L; Lambert BL
Am J Health Syst Pharm; 2019 Apr; 76(8):537-542. PubMed ID: 30915453
[TBL] [Abstract][Full Text] [Related]
4. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA
Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313
[TBL] [Abstract][Full Text] [Related]
5. INTEGRATING HEALTH TECHNOLOGY ASSESSMENT PRINCIPLES IN FORMULARY MANAGEMENT.
Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP
Int J Technol Assess Health Care; 2016 Jan; 32(1-2):81-7. PubMed ID: 27001376
[TBL] [Abstract][Full Text] [Related]
6. Use of an Innovative Pharmaceutical Class Scoring Tool for Prioritized Annual Formulary Review.
Sheldon H; Kostrzewa A; Werner S; Audley T; Biggs A; Mancuso T; Picone MF
Innov Pharm; 2022; 13(2):. PubMed ID: 36654702
[No Abstract] [Full Text] [Related]
7. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
Segal R; Pathak DS
Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
[TBL] [Abstract][Full Text] [Related]
8. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report.
Fry RN; Avey SG; Sullivan SD
Value Health; 2003; 6(5):505-21. PubMed ID: 14627057
[TBL] [Abstract][Full Text] [Related]
9. 6-STEPPPs: A Modular Tool to Facilitate Clinician Participation in Fair Decisions for Funding New Cancer Drugs.
Browman GP; Manns B; Hagen N; Chambers CR; Simon A; Sinclair S
J Oncol Pract; 2008 Jan; 4(1):2-7. PubMed ID: 20859436
[TBL] [Abstract][Full Text] [Related]
10. Drug formulary decision-making in two regional health authorities in British Columbia, Canada.
Armstrong K; Mitton C; Carleton B; Shoveller J
Health Policy; 2008 Dec; 88(2-3):308-16. PubMed ID: 18508151
[TBL] [Abstract][Full Text] [Related]
11. Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
Durán-García E; Santos-Ramos B; Puigventos-Latorre F; Ortega A
Int J Clin Pharm; 2011 Jun; 33(3):475-83. PubMed ID: 21416393
[TBL] [Abstract][Full Text] [Related]
12. A survey of selective administration procedures in formulary maintenance.
Quigley MA; Brown WM
Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of angiotensin II receptor blockers for drug formulary using objective scoring analytical tool.
Lim TM; Ibrahim MI
Pharm Pract (Granada); 2012 Jul; 10(3):136-42. PubMed ID: 24155829
[TBL] [Abstract][Full Text] [Related]
14. Transparency in evidence evaluation and formulary decision-making: from conceptual development to real-world implementation.
Dean BB; Ko KJ; Graff JS; Localio AR; Wade R; Dubois RW
P T; 2013 Aug; 38(8):465-83. PubMed ID: 24222979
[TBL] [Abstract][Full Text] [Related]
15. The formulary decision-making process in a US academic medical centre.
Nash DB; Catalano ML; Wordell CJ
Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
[TBL] [Abstract][Full Text] [Related]
16. Computer-based support system for formulary decisions.
Senthilkumaran K; Shatz SM; Kalies RF
Am J Hosp Pharm; 1987 Jun; 44(6):1362-6. PubMed ID: 3618613
[TBL] [Abstract][Full Text] [Related]
17. The use of economic evaluations in NHS decision-making: a review and empirical investigation.
Williams I; McIver S; Moore D; Bryan S
Health Technol Assess; 2008 Apr; 12(7):iii, ix-x, 1-175. PubMed ID: 18373906
[TBL] [Abstract][Full Text] [Related]
18. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
[TBL] [Abstract][Full Text] [Related]
19. Formulary evaluation of third-generation cephalosporins using decision analysis.
Cano SB; Fujita NK
Am J Hosp Pharm; 1988 Mar; 45(3):566-9. PubMed ID: 3285673
[TBL] [Abstract][Full Text] [Related]
20. MULTI-CRITERIA DECISION ANALYSIS AS A DECISION-SUPPORT TOOL FOR DRUG EVALUATION: A PILOT STUDY IN A PHARMACY AND THERAPEUTICS COMMITTEE SETTING.
Roldán ÚB; Badia X; Marcos-Rodríguez JA; de la Cruz-Merino L; Gómez-González J; Melcón-de Dios A; Caraballo-Camacho MO; Cordero-Ramos J; Alvarado-Fernández MD; Galiana-Auchel JM; Calleja-Hernández MÁ
Int J Technol Assess Health Care; 2018 Jan; 34(5):519-526. PubMed ID: 30348241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
